Berlin, 27th February 2015 – The teams led by Marie-Laure Yaspo at the Max Planck Institute for Molecular Genetics and by Hans Lehrach at Alacris Theranostics GmbH in Berlin are partners in a European consortium that recently obtained funding from the European Commission under the Horizon 2020 program to participate in a clinical research project […]
Alacris is proud to be one of the four finalists in the category „Start-Up-Companies“. A committee of representatives from industry and science considered the 200 applications. Criteria for the award alongside the level of innovation are marketability, innovation management and sustainability of the business concept. The oldest innovation award in the world is awarded in […]